What is the recommended dose of Co-Amoxiclav (amoxicillin/clavulanic acid) for a child weighing 16.9 kg using a 457mg/5ml suspension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav Dosing for a 16.9 kg Child

For a 16.9 kg child, the recommended dose is 90 mg/kg/day of the amoxicillin component divided into 2 doses, which equals 760.5 mg twice daily, administered as 8.3 mL of the 457 mg/5 mL suspension twice daily. 1

Dosing Calculation

Standard High-Dose Regimen

  • The preferred dosing for most pediatric infections is 90 mg/kg/day of the amoxicillin component divided into 2 doses, particularly for respiratory tract infections in areas with high pneumococcal resistance or when β-lactamase-producing organisms are suspected 1, 2

  • For a 16.9 kg child:

    • Total daily dose: 16.9 kg × 90 mg/kg = 1,521 mg/day 1
    • Per-dose amount: 1,521 mg ÷ 2 = 760.5 mg per dose 1

Volume Calculation with 457 mg/5 mL Suspension

  • The 457 mg/5 mL suspension contains 91.4 mg of amoxicillin per mL 3

  • Volume per dose: 760.5 mg ÷ 91.4 mg/mL = 8.3 mL twice daily 1, 3

  • Administer 8.3 mL of the suspension every 12 hours 1

Alternative Standard-Dose Regimen

  • For mild to moderate infections where resistant pathogens are less likely, a standard dose of 45 mg/kg/day divided into 2 doses may be used 1, 2

  • For a 16.9 kg child using standard dosing:

    • Total daily dose: 16.9 kg × 45 mg/kg = 760.5 mg/day 1
    • Per-dose amount: 760.5 mg ÷ 2 = 380.25 mg per dose 1
    • Volume per dose: 380.25 mg ÷ 91.4 mg/mL = 4.2 mL twice daily 1

Clinical Context for Dose Selection

When to Use High-Dose (90 mg/kg/day)

  • Respiratory tract infections including pneumonia 1, 4
  • Recent antibiotic exposure within the past 3 months 1
  • Areas with high pneumococcal resistance 1, 2
  • Suspected β-lactamase-producing Haemophilus influenzae 1, 2
  • Inadequate H. influenzae type b vaccination 1
  • Concurrent purulent acute otitis media 1

When Standard-Dose (45 mg/kg/day) May Be Appropriate

  • Mild to moderate infections without risk factors for resistance 1, 2
  • Group A Streptococcal infections (though 50-75 mg/kg/day is preferred for this indication) 1

Administration Guidelines

  • Administer at the start of meals to minimize gastrointestinal intolerance 3
  • Shake suspension well before each use 3
  • Store reconstituted suspension in refrigerator (preferred but not required) 3
  • Discard any unused suspension after 14 days 3

Treatment Duration

  • Continue treatment for 7-10 days for most respiratory infections 1
  • For pneumonia specifically, treat for 10 days 1, 4
  • Treat for a minimum of 48-72 hours beyond symptom resolution 1, 4

Maximum Dose Considerations

  • The absolute maximum daily dose is 4,000 mg of amoxicillin component per day, regardless of weight 2
  • At 90 mg/kg/day, this 16.9 kg child receives 1,521 mg/day, which is well below the maximum 2

Common Pitfalls to Avoid

  • Do not use the 875 mg tablet formulation in children under 40 kg 3
  • Do not confuse the amoxicillin component dose with the total Co-Amoxiclav dose (the suspension contains both amoxicillin and clavulanic acid) 2, 3
  • Avoid underdosing in the setting of resistant pathogens by using 90 mg/kg/day rather than 45 mg/kg/day when indicated 1, 2
  • Do not extend dosing intervals beyond 12 hours for the twice-daily regimen, as this compromises the time above MIC 1
  • Ensure clinical improvement within 48-72 hours; if no improvement occurs, reevaluation is necessary 1

References

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Dose of Augmentin for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hospital Management of Bronchopneumonia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.